physIQ Heart Rhythm and Respiratory Module vs Tempus ECG-AF
AI Verdict
Choose physIQ Heart Rhythm and Respiratory Module if…
Choose physIQ Heart Rhythm and Respiratory Module if you require continuous, real-time physiological monitoring of patients using wearable biosensors to detect subtle changes from an individualized baseline. This tool is ideal for proactive management and early intervention, particularly in critical care, cardiology, or pulmonology settings where continuous insight into heart rhythm and respiratory rate is crucial for identifying decompensation.
View physIQ Heart Rhythm and Respiratory Module →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to identify older patients (65+) at an increased risk of developing new-onset atrial fibrillation within the next 12 months using existing 12-lead ECG data. This solution is best suited for risk stratification and supporting earlier follow-up in a clinical setting, leveraging AI to predict future AF risk rather than providing continuous real-time monitoring.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | physIQ Heart Rhythm and Respiratory Module | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Cloud-based platform | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
physIQ Heart Rhythm and Respiratory ModuleTool A, physIQ, leverages continuous wearable biosensor data and a cloud-based platform, which can offer greater patient convenience and less intrusive data collection compared to episodic clinical tests. Its remote monitoring capabilities suggest a more flexible and accessible approach to data acquisition for ongoing patient management.
Clinical Value
physIQ Heart Rhythm and Respiratory ModuleTool A provides broader clinical value through AI-based personalized physiology analytics, continuously monitoring for subtle changes, early signs of decompensation, heart rate, respiration rate, and atrial fibrillation. This comprehensive, real-time, and personalized insight from continuous data offers a wider range of actionable clinical information than Tool B's specific predictive risk for AFib from a single ECG.
Pricing & Value
Tempus ECG-AFTool B, Tempus ECG-AF, explicitly details CMS reimbursement availability with specific CPT codes and a Medicare rate, providing clear financial transparency and a strong value proposition for healthcare providers. Tool A, physIQ, only states 'contact for pricing,' offering no immediate insight into its financial viability or reimbursement pathways.
Enterprise Readiness
physIQ Heart Rhythm and Respiratory ModuleBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, demonstrating strong foundational readiness. However, Tool A explicitly labels itself as an 'industry-leading, enterprise-ready cloud platform,' suggesting a more inherently scalable and flexible infrastructure designed for diverse enterprise integration and deployment needs beyond specific system compatibility.
Innovation
physIQ Heart Rhythm and Respiratory ModuleTool A's innovation lies in its AI-based personalized physiology analytics that learns individual patient baselines and detects subtle, personalized physiological changes from continuous wearable data. This adaptive, continuous learning model for proactive health monitoring represents a more advanced and personalized approach to digital medicine compared to Tool B's predictive algorithm on a standard diagnostic test.
Support & Docs
Tempus ECG-AFTool B, Tempus AI, provides explicit contact information for customer support via email and phone, and mentions local representatives, indicating clear channels for assistance. In contrast, no specific support or documentation details for physIQ's Heart Rhythm and Respiratory Module were found in the provided facts or relevant web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | physIQ Heart Rhythm and Respiratory Module | Tempus ECG-AF |
|---|---|---|
| Name | physIQ Heart Rhythm and Respiratory Module | Tempus ECG-AF |
| Company | physIQ | Tempus AI, Inc. |
| Primary Data Source | Continuous wearable biosensor data | 12-lead ECG recordings |
| Key Functionality | AI-based personalized physiology analytics, continuous biosensor data collection, detects subtle physiological changes, calculates heart rate/variability, detects atrial fibrillation, determines respiration rate | AI-based algorithm analyzes 12-lead ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within 12 months |
| Target Patient Population | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
Videos
Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and Tempus ECG-AF.